![Quiver Logo](/static/img/logo-icon.png)
![WGSWW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/wgsww.png)
GeneDx Holdings Corp. Warrant
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view WGSWW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of WGSWW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by WGSWW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to WGSWW
Recent picks made for WGSWW stock on CNBC
ETFs with the largest estimated holdings in WGSWW
Flights by private jets registered to WGSWW
![Quiver Logo](/static/img/logo-icon.png)